Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1087424

The efficacy and safety of valsartan and a combination of valsartan and hydrochlorothiazide in the treatment of patients with mild to moderate arterial hypertension: a subgroup analysis of the effect of valsartan and its combination with hydrochlorothiazide on pulse wave velocity and central blood pressure


Accetto, Rok; Widimsky Jr, Jiri; Vincelj, Josip; Sirenko, Yuriy; Chazova Yevgenyevna, Irina; Barbić Žagar, Breda
The efficacy and safety of valsartan and a combination of valsartan and hydrochlorothiazide in the treatment of patients with mild to moderate arterial hypertension: a subgroup analysis of the effect of valsartan and its combination with hydrochlorothiazide on pulse wave velocity and central blood pressure // Kardiologia Polska, 76 (2018), 2; 328-337 doi:10.5603/KPa2017.0240 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1087424 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
The efficacy and safety of valsartan and a combination of valsartan and hydrochlorothiazide in the treatment of patients with mild to moderate arterial hypertension: a subgroup analysis of the effect of valsartan and its combination with hydrochlorothiazide on pulse wave velocity and central blood pressure

Autori
Accetto, Rok ; Widimsky Jr, Jiri ; Vincelj, Josip ; Sirenko, Yuriy ; Chazova Yevgenyevna, Irina ; Barbić Žagar, Breda

Izvornik
Kardiologia Polska (0022-9032) 76 (2018), 2; 328-337

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Pulse wave analysis ; Antihypertensive agent ; Valsartan ; Clinical trial
(pulse wave analysis ; antihypertensive agent ; valsartan ; clinical trial)

Sažetak
The aim of the study was to establish the effect of valsartan and combination of valsartan and hydrochlorothiazide (HCTZ) od pulse wave velocity (PWV) and central blood pressure (CBP) in a large population of patients with mild to moderate arterial hypertension. This was an international, multicentre, open-label, prospective trial. After one week of washout in previously treated patients, 74 subjects were treated with valsartan or valsartan combined with HCTZ for 16 weeks according to the protocol. During the active treatment, four visits were planned for each patient to obtain data for the primary and secondary efficacy. At the beginning and at the end of the study PWV and CBP were determined with central arterial pressure waveform analysis (SphygmoCor, Atcor Medical). This study is registered with clinicaltrialsregister.eu, EudraCT number 2012-005129-57. The results of the present VICTIRY trial showed that valsartan and combination of valsartan and HCTZ effectively reduced the brachial blood pressure in patients with mild to moderate arterial hypertension as well as PWV, central systolic blood pressure and central diastolic blood pressure. The effects on the augmentation index were not statistically significant. Valsartan and valsartan/HCTZ improve arterial stiffness in patients with mild to moderate hypertension

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Klinička bolnica "Dubrava",
Medicinski fakultet, Osijek,
Sveučilište J. J. Strossmayera u Osijeku

Profili:

Avatar Url Josip Vincelj (autor)

Poveznice na cjeloviti tekst rada:

doi kardiologiapolska.pl

Citiraj ovu publikaciju:

Accetto, Rok; Widimsky Jr, Jiri; Vincelj, Josip; Sirenko, Yuriy; Chazova Yevgenyevna, Irina; Barbić Žagar, Breda
The efficacy and safety of valsartan and a combination of valsartan and hydrochlorothiazide in the treatment of patients with mild to moderate arterial hypertension: a subgroup analysis of the effect of valsartan and its combination with hydrochlorothiazide on pulse wave velocity and central blood pressure // Kardiologia Polska, 76 (2018), 2; 328-337 doi:10.5603/KPa2017.0240 (međunarodna recenzija, članak, znanstveni)
Accetto, R., Widimsky Jr, J., Vincelj, J., Sirenko, Y., Chazova Yevgenyevna, I. & Barbić Žagar, B. (2018) The efficacy and safety of valsartan and a combination of valsartan and hydrochlorothiazide in the treatment of patients with mild to moderate arterial hypertension: a subgroup analysis of the effect of valsartan and its combination with hydrochlorothiazide on pulse wave velocity and central blood pressure. Kardiologia Polska, 76 (2), 328-337 doi:10.5603/KPa2017.0240.
@article{article, author = {Accetto, Rok and Widimsky Jr, Jiri and Vincelj, Josip and Sirenko, Yuriy and Chazova Yevgenyevna, Irina and Barbi\'{c} \v{Z}agar, Breda}, year = {2018}, pages = {328-337}, DOI = {10.5603/KPa2017.0240}, keywords = {Pulse wave analysis, Antihypertensive agent, Valsartan, Clinical trial}, journal = {Kardiologia Polska}, doi = {10.5603/KPa2017.0240}, volume = {76}, number = {2}, issn = {0022-9032}, title = {The efficacy and safety of valsartan and a combination of valsartan and hydrochlorothiazide in the treatment of patients with mild to moderate arterial hypertension: a subgroup analysis of the effect of valsartan and its combination with hydrochlorothiazide on pulse wave velocity and central blood pressure}, keyword = {Pulse wave analysis, Antihypertensive agent, Valsartan, Clinical trial} }
@article{article, author = {Accetto, Rok and Widimsky Jr, Jiri and Vincelj, Josip and Sirenko, Yuriy and Chazova Yevgenyevna, Irina and Barbi\'{c} \v{Z}agar, Breda}, year = {2018}, pages = {328-337}, DOI = {10.5603/KPa2017.0240}, keywords = {pulse wave analysis, antihypertensive agent, valsartan, clinical trial}, journal = {Kardiologia Polska}, doi = {10.5603/KPa2017.0240}, volume = {76}, number = {2}, issn = {0022-9032}, title = {The efficacy and safety of valsartan and a combination of valsartan and hydrochlorothiazide in the treatment of patients with mild to moderate arterial hypertension: a subgroup analysis of the effect of valsartan and its combination with hydrochlorothiazide on pulse wave velocity and central blood pressure}, keyword = {pulse wave analysis, antihypertensive agent, valsartan, clinical trial} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Uključenost u ostale bibliografske baze podataka::


  • EMBASE (Excerpta Medica)
  • Index Copernicus
  • EBSCO
  • Cros Ref


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font